{"id":"W2581612511","doi":"10.1007/s41669-017-0011-x","title":"Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK","year":2017,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"Astellas Pharma Global Development; Astellas Pharma Europe; Astellas Pharma; Canadian Urological Association; Duchesnay; Pfizer","keywords":"Mirabegron; Tolterodine; Overactive bladder; Oxybutynin; Solifenacin; Medicine; Urology; Cohort; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005598012,0.0001442564,0.0003830746,0.00005213814,0.0001594764,0.00009806072,0.0007539214,0.00003858863,0.0004994124],"category_scores_gemma":[0.00002142084,0.00008256004,0.0002430248,0.00001510621,0.0001340426,0.0002337769,0.0001293567,0.0001064668,0.00001523717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003024018,"about_ca_system_score_gemma":0.00049351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005453008,"about_ca_topic_score_gemma":0.0003134447,"domain_scores_codex":[0.999148,0.00004970907,0.0003051586,0.0002084612,0.00005436514,0.0002343085],"domain_scores_gemma":[0.9981166,0.0008365727,0.0002665601,0.0006849784,0.00003801007,0.00005727632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1806136,0.007175772,0.3728373,0.0004017968,0.02106953,0.00008298884,0.0303879,0.008538761,0.00940303,0.003533005,0.04440452,0.3215518],"study_design_scores_gemma":[0.10779,0.02313493,0.6707538,0.00008602317,0.001869581,0.00005450952,0.002611003,0.05513667,0.05183415,0.001149434,0.08481139,0.0007685757],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9838906,0.0003536222,0.000003363732,0.001625247,0.0002135195,0.002561723,0.0003302307,0.000001829116,0.01101988],"genre_scores_gemma":[0.9950272,0.004304728,0.00004792422,0.00005944557,0.0001311744,0.0001543808,0.00002898664,0.00001819421,0.000227912],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3207832,"threshold_uncertainty_score":0.8243353,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1589304446283486,"score_gpt":0.5192326041491452,"score_spread":0.3603021595207966,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}